Seasonal Affective Disorder; a Mood Disorder Characterized By Depression That Occurs At the Same Time Every Year

Seasonal Affective Disorder
Seasonal Affective Disorder

Seasonal Affective Disorder (SAD), also called major depressive disorder with seasonal pattern, is a form of depression. It is a mood disorder subset, in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year. It is another term for major depressive disorder (MDD) with seasonal pattern. It is a type of depression that is provoked by seasonal change. SAD most often occurs in women and young adults, particularly those who live farther north.

The Seasonal Affective Disorder Market is anticipated to reach US$ 544.7 million in 2020 and grow at a CAGR of 5.5% during the following five years (2020-2027).

This type of depression is related to changes in seasons and begins and ends at the same time every year. It is a type of depression that comes and goes in a seasonal pattern. SAD is sometimes known as winter depression because the signs and symptoms are usually more apparent and more severe during the winter. The treatment for SAD may include psychotherapy, light therapy, and medications. It is subtype of bipolar disorder. People diagnosed with bipolar disorder experience seasonal patterns in their symptoms.

SAD is a mental health condition that is triggered by the changing of the seasons. The risk of SAD increases with age. It's rare in people under age of 20. Women are affected more often than men. Thus, there is an increasing demand for safe & effective Seasonal Affective Disorder treatment. Antidepressants are thought to be most effective if taken at the start of winter before symptom appear, and continued until spring. SSRIs (Selective Serotonin Reuptake Inhibitors) are the preferred type of antidepressant for treating SAD.

Anticonvulsants Drugs were initially developed to treat epileptic patients. The primary symptoms of epilepsy are recurrent seizures, which are brief bursts of electrical activity in the brain that temporarily impede brain function.

Other types of antidepressants can also be used instead of SSRIs. APLENZIN is an antidepressant indicated for the prevention of SAD and treatment of MDD. It is the only FDA (the Food and Drug Administration) approved bupropion hydrobromide indicated for the prevention of SAD and offers more than 20 years of combined clinical experience in MDD and SAD.

Comments

Popular posts from this blog

Vehicle-To-Vehicle (V2V) Communication; Used To Wirelessly Interchange Data Regarding Their Speed, Place, And Heading

Global Polyphenol Market Is Expanding Owing To Growing Development Of Polyphenol-Rich Products For Health Improvement

Global Ferrous Sulfate Market Is Anticipated To Witness High Growth Due To Growing Demand In The Water Treatment Segment And Increasing Applications In Cement And Agriculture